Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (141-150 of 197) with videos related to

Pageof 20
Sort By:
Medicine|February 1, 2018
Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)Satoshi Nishiwaki, Isamu Sugiura, Yasuhiko Miyata, et al.
Cancer Science|February 27, 2016
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugsYoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, et al.
Ejhaem|May 19, 2023
Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 studySatoshi Nishiwaki, Isamu Sugiura, Takahiko Sato, et al.
Vaccine|September 19, 2009
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, et al.
Blood|July 28, 2016
Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gutKazuhiko Kakihana, Yuki Fujioka, Wataru Suda, et al.
Cancer Discovery|November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal diseaseJun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY)Keiju Aokage, Shohei Koyama, Shogo Kumagai, et al.
Science Immunology|October 7, 2022
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumorsKota Itahashi, Takuma Irie, Junichiro Yuda, et al.
Haematologica|July 7, 2018
Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in JapanNaoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, et al.
Nature Communications|December 15, 2021
Depletion of central memory CD8<sup>+</sup> T cells might impede the antitumor therapeutic effect of MogamulizumabYuka Maeda, Hisashi Wada, Daisuke Sugiyama, et al.
Pageof 20

Showing results (141-150 of 197) with videos related to

Sort By:
Pageof 20
Medicine|February 1, 2018
Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)Satoshi Nishiwaki, Isamu Sugiura, Yasuhiko Miyata, et al.
Cancer Science|February 27, 2016
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugsYoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, et al.
Ejhaem|May 19, 2023
Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 studySatoshi Nishiwaki, Isamu Sugiura, Takahiko Sato, et al.
Vaccine|September 19, 2009
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, et al.
Blood|July 28, 2016
Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gutKazuhiko Kakihana, Yuki Fujioka, Wataru Suda, et al.
Cancer Discovery|November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal diseaseJun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY)Keiju Aokage, Shohei Koyama, Shogo Kumagai, et al.
Science Immunology|October 7, 2022
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumorsKota Itahashi, Takuma Irie, Junichiro Yuda, et al.
Haematologica|July 7, 2018
Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in JapanNaoto Takahashi, Kaichi Nishiwaki, Chiaki Nakaseko, et al.
Nature Communications|December 15, 2021
Depletion of central memory CD8<sup>+</sup> T cells might impede the antitumor therapeutic effect of MogamulizumabYuka Maeda, Hisashi Wada, Daisuke Sugiyama, et al.
Pageof 20